Dr Eijkenboom is an R&D and commercialisation executive with 20 years multinational, ASX-listed, private, start-up, incubator, spin-out and consulting experience in the life sciences industry. She has invented and/or developed a wide range of technologies, including drugs, devices, biologics, veterinary, complementary medicines, cosmetics, nutraceuticals and agrochemicals. She was Chief Scientific Officer for ASX-Listed entities and R&D executive for Bayer HealthCare in Germany. Maud is passionate about creating flow between universities, the healthcare system, industry and the community to improve quality of life. Maud has scientific qualifications in preclinical neuropsychology and neurobiology. She is an Expert in the Commercialisation Australia Expert Network and previously an advisor to the Innovation Centre of WA.